Cargando…
Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is the major dose-limiting side effect of many commonly used chemotherapeutic agents, including paclitaxel. Currently, there are no neuroprotective or effective symptomatic treatments for CIPN. Lack of understanding of the in vivo mechanisms of CIPN...
Autores principales: | Brazill, Jennifer M., Cruz, Beverley, Zhu, Yi, Zhai, R. Grace |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031360/ https://www.ncbi.nlm.nih.gov/pubmed/29716954 http://dx.doi.org/10.1242/dmm.032938 |
Ejemplares similares
-
Alternative splicing of Drosophila Nmnat functions as a switch to enhance neuroprotection under stress
por: Ruan, Kai, et al.
Publicado: (2015) -
MicroRNA miR-1002 Enhances NMNAT-Mediated Stress Response by Modulating Alternative Splicing
por: Park, Joun, et al.
Publicado: (2019) -
The PINK1 Activator Niclosamide Mitigates Mitochondrial Dysfunction and Thermal Hypersensitivity in a Paclitaxel-Induced Drosophila Model of Peripheral Neuropathy
por: Jang, Hye-Ji, et al.
Publicado: (2022) -
Human Nmnat1 Promotes Autophagic Clearance of Amyloid Plaques in a Drosophila Model of Alzheimer’s Disease
por: Zhu, Yi, et al.
Publicado: (2022) -
Drosophila NMNAT Maintains Neural Integrity Independent of Its NAD Synthesis Activity
por: Zhai, R. Grace, et al.
Publicado: (2006)